Morepen Logo
Morepen Logo
  • Home
  • About Morepen
  • Business Segment
  • Research & Development
  • Investors
  • Media Kit
  • Contact Us
  • Company Profile
  • Mission & Values
  • Our History
  • Leadership
    • Board of Directors
    • Management Team
  • Morepen Presence
  • Company Social Responsibility
  • Environment Monitoring
  • Active Pharmaceutical Ingredients
    • Overview
    • Product Information
    • Intermediate
    • Drug Master Files
    • Regulated Market
    • Non Regulated Market
  • Formulations
    • Overview
    • Branded Prescription Drugs
    • Catalogue
  • Diagnostics
    • Overview
    • Home Health
    • Clinical Diagnostics
    • Service / Demo Request
  • Dr. Morepen
    • Overview
    • Products
  • Overview
  • Product in Development
  • Chemistry Skills
  • Quality Control
  • Manufacturing Facilities
    • Masulkhana
    • Parwanoo
    • Baddi
  • Financial Results
  • Share Holding Pattern
  • Code of Conduct
  • Green Initiative
  • News Room
  • Videos
  • News Room
  • Videos

Home > Media KIt > News Room

News Rooms

Unaudited Financial Results For the Quarter ended 31st December, 2011
Unaudited Financial Results For the Quarter ended 30 September, 2011
Patent Award
Unaudited Financial Results For the Quarter ended 30 June, 2011
Morepen gets USFDA approval for Desloratadine 
Audited Financial Results For the Quarter and Year ended 31st March 2011
Morepen to Double Montelukast Production
Unaudited Financial Results For the Quarter ended 31st December, 2010
Unaudited Financial Results For the Quarter ended 30th September, 2010
Unaudited Financial Results For the Quarter ended 30th June, 2010
Shareholding pattern as on 31st December 2009
Unaudited Financial Results for the Quarter ended 31st December, 2009
Unaudited Financial Results for the Quarter ended 30th September, 2009
Shareholding pattern as on 30th September 2009
Unaudited Financial Results for the Quarter ended 30th June, 2009
Audited Financial Results for the Year ended 31st March, 2009
Unaudited Financial Results for the Quarter ended 31st December, 2008
 
Next Page

 

Home | Contact Us | Sitemap
© Copyright 2010. All Rights Reserved.